Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors.
The suramin analogue 8,8'-(carbonylbis(imino-3,1-phenylene carbonylimino)bis(1,3,5-naphthalenetrisulfonic acid) (NF023) antagonizes in a competitive fashion P2X receptor-mediated responses in certain vascular and visceral smooth muscles. In the present study, the effect of NF023 on voltage-clamped Xenopus oocytes heterologously expressing homomultimeric P2X1-P2X4 as well as heteromultimeric P2X2/P2X3 receptors has been characterized. P2X1 receptors were most sensitive to inhibition by NF023 with IC50 values of 0.24 and 0.21 microM for the rat and human homologue, respectively. P2X3 receptors have an intermediate sensitivity with IC50 values of 8.5 and 28.9 microM for rat and human subtypes, respectively and P2X2 was the least sensitive subtype (IC50 > 50 microM). P2X4 receptors were insensitive to NF023 at concentrations up to 100 microM. Coexpression of rat P2X3 with rat P2X2 resulted in receptors whose sensitivity to NF023 was identical to that obtained for homomultimeric rat P2X3 receptors (alphabeta meATP as agonist; IC50 = 1.4 and 1.6 microM, respectively). NF023 inhibited P2X1 receptors in a voltage-insensitive manner. In addition, NF023 (5 and 30 microM) caused a shift of the concentration-response curve to the right without affecting the maximal response to ATP (K(B) = 1.1 +/- 0.2 microM). Our results indicate that NF023 is a subtype-selective and surmountable antagonist at P2X1 receptors heterologously expressed in Xenopus oocytes.
Soto
F
F
Max-Planck Institute for Experimental Medicine, Göttingen, Germany. soto@mail.mpiem.gwdg.de
Lambrecht
G
G
Nickel
P
P
Stühmer
W
W
Busch
A E
AE
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D003001:Cloning, Molecular; D008564:Membrane Potentials / Q000187:drug effects; D009865:Oocytes / Q000187:drug effects; D018408:Patch-Clamp Techniques; D058919:Purinergic P2 Receptor Antagonists; D013498:Suramin / Q000031:analogs & derivatives* / Q000494:pharmacology; D014982:Xenopus laevis
C105374:NF023; D058919:Purinergic P2 Receptor Antagonists; D013498:Suramin; D000255:Adenosine Triphosphate